Therapy Areas: Oncology
Arcus Biosciences enters clinical trial collaboration with Bristol Myers Squibb in kidney cancer programme
3 June 2026 - Clinical-stage biopharmaceutical company Arcus Biosciences Inc (NYSE:RCUS) announced on Wednesday that it has entered into a clinical trial collaboration and supply agreement with biopha...
Lupin and Natco secure US FDA approval for generic Eribulin Mesylate Injection
...
Evogene completes Phase 1 study of BMC128 in combination with Nivolumab
3 June 2026 - Computational chemistry company Evogene Ltd (Nasdaq:EVGN) (TASE:EVGN) announced on Tuesday the successful completion of the first-in-human (FIH) Phase 1 clinical study of BMC128, a ratio...
Cumberland Pharmaceuticals and Vanderbilt Health report data from Phase 2a trial of ifetroban to prevent cancer metastasis
3 June 2026 - Specialty pharmaceutical company Cumberland Pharmaceuticals Inc (Nasdaq:CPIX) and healthcare provider Vanderbilt Health on Tuesday announced data from a Phase 2a clinical trial of ifetro...
Creatv Bio partners with Neovia Oncology to study multiple drug resistance in solid tumours
3 June 2026 - Creatv Bio, a division of Creatv MicroTech Inc, a liquid biopsy company focused on innovative diagnostics for cancer, and Neovia Oncology LLC, a pharmaceutical company developing novel o...
FDA accepts Genentech's giredestrant application for early-stage breast cancer
2 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug Appli...